Crystal Pharmatech
The group connects candidates with clinical and commercial supply through solid-state, preformulation, oral formulation development, and manufacturing services. Formulation execution entities include CFS and Candoo.
Corporate information
- Company entity
- Crystal Pharmatech
- Headquarters / principal office
- Cranbury, New JerseySelf-reported location on the company LinkedIn page; regional scope may differ from the legal or global headquarters. ↗
- Founded
- 2010 ↗
- Ownership / capital status
- PrivateSeries B (disclosed in 2018) ↗
- Official corporate reference
- https://www.crystalpharmatech.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
- Latest financing / award identified
- 2018 · Series B · USD 14.5 million ↗
Disclosed in the official company history, with year-level precision only; this does not establish that there was no subsequent financing by the access date.
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
The group connects candidates with clinical and commercial supply through solid-state, preformulation, oral formulation development, and manufacturing services. Formulation execution entities include CFS and Candoo.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.